etoposide has been researched along with Sarcoma, Ewing in 161 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.62) | 18.7374 |
| 1990's | 26 (16.15) | 18.2507 |
| 2000's | 53 (32.92) | 29.6817 |
| 2010's | 57 (35.40) | 24.3611 |
| 2020's | 24 (14.91) | 2.80 |
| Authors | Studies |
|---|---|
| Saeed, H; Sarfraz, S | 1 |
| Bauer, S; Baumhoer, D; Bernkopf, M; Bhadri, V; Bonar, F; Bovee, J; Brichard, B; Burdach, S; Butterfaß-Bahloul, T; Collaud, S; Cyprova, S; Dhooge, C; Dirksen, U; Egerer, G; Eich, HT; Ek, T; Faldum, A; Gelderblom, H; Hardes, J; Hartmann, W; Hassenpflug, W; Hauser, P; Haveman, L; Hjorth, L; Hong, A; Jürgens, H; Kanerva, J; Kessler, T; Kiss, J; Koch, R; Kruseova, J; Kühne, T; Metzler, M; Paulussen, M; Raciborska, A; Ranft, A; Rascon, J; Reichardt, P; Renard, M; Timmermann, B; van den Berg, H; Vieth, V | 1 |
| Ghandour, K; Halalsheh, H; Ibrahimi, AKH; Ismael, T; Sarhan, N; Shehadeh, A; Sultan, I; Zandaki, D | 1 |
| Bajpai, J; Chatterjee, A; Chinnaswamy, G; Desai, S; Gulia, A; Jambhekar, N; Janu, A; Juvekar, S; Khanna, N; Kurkure, P; Laskar, S; Manjali, JJ; Muckaden, MA; Nayak, P; Prasad, M; Purandare, N; Puri, A; Rangarajan, V; Rekhi, B; Shah, S; Sinha, S; Vora, T | 1 |
| Bach, E; Brückner, M; Franke, GN; Heyn, S; Jentzsch, M; Leiblein, S; Niederwieser, D; Pfannes, R; Platzbecker, U; Pönisch, W; Remane, Y; Rieprecht, S; Schwind, S; Vucinic, V | 1 |
| Lucari, B; Porea, T; Sutton, VR; Tallis, E | 1 |
| Bompas, E; Brugières, L; Castex, MP; Chevreau, C; Cleirec, M; Corvest, V; Duranteau, L; Entz-Werle, N; Filhon, B; Flandrin, J; Fresneau, B; Gaspar, N; Gentet, JC; Guimard, G; Jimenez, M; Laurence, V; Le Deley, MC; Lervat, C; Mansuy, L; Marec-Bérard, P; Pacquement, H; Pondrom, M; Rousset-Jablonski, C; Saumet, L; Tabone, MD; Taque, S; Toulmonde, M; Verité, C | 1 |
| Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY | 1 |
| Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Arndt, C; Boron, M; Buxton, A; Chen, HX; Crompton, BD; Daldrup-Link, H; DuBois, SG; Eutsler, E; Glade-Bender, J; Gorlick, RG; Hayes, A; Hill-Kayser, C; Janeway, KA; Kolb, EA; Krailo, MD; Laack, N; Lessnick, SL; Rakheja, D; Randall, RL; Reed, DR; Reid, JM; Seibel, NL; Teot, L; Terezakis, S; Womer, R | 1 |
| Bailey, KM; Daley, J; Friehling, E; Halligan, K; Howrie, D; Salgado, CM; Superdock, A | 1 |
| Goldin, AN; Healey, RM | 1 |
| Ahmed, SK; Allen-Rhoades, W; Heidenreich, MJ; Houdek, MT; Petersen, IA; Robinson, SI; Rose, PS; Siontis, BL | 1 |
| Aiba, H; Arakawa, A; Imai, T; Iwata, S; Kawai, A; Kimura, H; Kobayashi, E; Kojima, Y; Ogawa, C; Shimoi, T; Sudo, K; Yazaki, S; Yonemori, K; Yoshida, A | 1 |
| Binitie, O; Buxton, AB; Cash, T; DuBois, SG; Gorlick, R; Grier, HE; Grohar, PJ; Healey, JH; Janeway, KA; Krailo, MD; Marcus, KJ; Pawel, BR; Reed, DR; Weiss, AR; Womer, RB | 1 |
| Abdelal, S; Abu-Hijlih, R; Abuhijla, F; Almousa, A; Halalsheh, H; Ismail, T; Jaber, O; Salah, S; Shehadeh, A; Sultan, I; Yaser, S | 1 |
| Khalifeh, I; Maroun, CA; Moukarbel, RV; Tfayli, A | 1 |
| Brohl, AS; Cubitt, CL; Fridley, B; Kahen, E; Reed, DR; Welch, D | 1 |
| Boehme, KA; Handgretinger, R; Lenz, JE; Riester, R; Schleicher, SB; Traub, F | 1 |
| He, A; Hu, H; Huang, Y; Shen, Z; Sun, Y; Yao, Y; Zhang, J; Zhou, Y | 1 |
| Anderton, J; Brennan, B; Evans, A; Fenwick, N; Fernández-Pinto, M; Gaspar, N; Gelderblom, H; Kaiser, S; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
| Eich, HT; Scobioala, S | 1 |
| Bansal, D; Jain, R; Kapoor, R; Rao, KLN; Samujh, R; Saxena, AK; Totadri, S; Trehan, A | 1 |
| Chumbalkar, V; Howe, AS; Kogan, BA; Lian, F; Nazeer, T; Pearce, J; Ribbons, L | 1 |
| Bajpai, J; Banavali, SD; Bhargava, P; Chandrasekharan, A; Dandekar, S; Gupta, S; Joshi, A; Khanna, N; Laskar, S; Menon, N; Mokal, S; Noronha, V; Panda, GS; Patil, V; Prabhash, K; Rekhi, B; Srinivas, S | 1 |
| Bielack, SS; Fuchs, J; Hallmen, E; Kazanowska, B; Klingebiel, T; Koscielniak, E; Ladenstein, R; Ljungman, G; Niggli, F; Paulussen, M; Scheer, M; Seitz, G; Sparber-Sauer, M; Vokuhl, C | 1 |
| Agarwala, S; Bakhshi, S; Batra, A; Dhawan, D; Gupta, YK; Pramanik, R; Thulkar, S; Vishnubhatla, S | 1 |
| Bruckner, T; Cremer, M; Egerer, G; Heilig, C; Kriegsmann, K; Kriegsmann, M; Müller-Tidow, C; Novotny, P; Wuchter, P | 1 |
| Ahmed, SK; DuBois, SG; Geller, DS; Gorlick, RG; Granowetter, L; Grier, HE; Harmsen, WS; Janeway, KA; Krailo, M; Laack, NNI; Marcus, KJ; Randall, RL; Sorger, JI; Womer, RB | 1 |
| Bagherifard, A; Jamshidi, K; Mirzaei, A; Ramezan Shirazi, M | 1 |
| Alnassan, A; Elshahoubi, A; Sultan, I | 1 |
| Azmy, V; Brooks, JP; Hsu, FI; Luon, D; Price, C; Prozora, SD; Thompson, A | 1 |
| Banavali, S; Devadas, SK | 1 |
| Akiyama, M; Fukushima, T; Ida, H; Kato, T; Sakurai, H; Terao, Y; Yamaoka, M; Yokoi, K; Yokokawa, Y | 1 |
| Clement, J; Drabick, JJ; Frauenhoffer, E; Rybka, W; Varlotto, J | 1 |
| Abate, ME; Balladelli, A; Cesari, M; Fagioli, F; Ferrari, S; Luksch, R; Marchesi, E; Paioli, A; Palmerini, E; Pratelli, L; Tamburini, A | 1 |
| Angelici, A; Brunotti, G; Manfredelli, S; Marcantonio, M; Pontone, S; Zitelli, A | 1 |
| Abujamra, AL; Brunetto, AL; de Farias, CB; Dos Santos, MP; Roesler, R | 1 |
| Fernández de Gamarra Martínez, E; Mangues Bafalluy, MA; Mullera Martí, M; Riba Solé, M | 1 |
| Brennan, B; Craft, A; Dirksen, U; Hjorth, L; Judson, I; Juergens, H; Ladenstein, R; Le Deley, MC; Le Teuff, G; Lewis, I; Marec-Bérard, P; Michon, J; Oberlin, O; Paulussen, M; Ranft, A; van den Berg, H; Wheatley, K; Whelan, J | 1 |
| Benson, C; Blay, JY; Dirksen, U; Gelderblom, H; Judson, I; Juergens, H; Placzke, J; Rasper, M; Rutkowski, P; van den Berg, H; van Maldegem, AM | 1 |
| Agarwala, S; Bakhshi, S; Biswas, B; Deo, SV; Khan, SA; Mohanti, BK; Rastogi, S; Sharma, MC; Shukla, NK; Vishnubhatla, S | 1 |
| Abujamra, AL; Almeida, MT; Benites, E; Boldrini, E; Brunetto, AL; Castillo, LA; Costa, C; Gadelha, A; Gregianin, LJ; Kirst, D; Macedo, CD; Morais, V; Nakasato, A; Pereira, WV; Petrilli, AS; Pizza, M; Rodriguez-Galindo, C; Watanabe, FM | 1 |
| Dufour, C; Gaspar, N; Goma, G; Loschi, S; Oberlin, O; Valteau-Couanet, D | 1 |
| Clemens, D; Dirksen, U; Frühwald, MC; Fulda, S; Heinicke, U; Hotfilder, M; Potratz, JC; Unland, R; Wardelmann, E | 1 |
| Beck, JF; Becker, S; Blümel, L; Blumrich, A; Kahl, M; Krämer, OH; Siranjeevi, PM; Sonnemann, J; Winkler, R; Wittig, S | 1 |
| DuBois, SG; Felgenhauer, J; Granowetter, L; Grier, HE; Karski, EE; Krailo, M; Marina, N; McIlvaine, E; Meyers, PA; Segal, MR; Womer, RB | 1 |
| Engert, F; Fulda, S; Probst, M; Schneider, C; Weiβ, LM | 1 |
| Caporossi, D; Fidaleo, M; Miñana, B; Paronetto, MP; Svetoni, F; Volpe, E | 1 |
| Bond, MC; Felgenhauer, JL; Femino, JD; Gorlick, R; Krailo, MD; Laack, NN; Marina, N; Mascarenhas, L; Meyer, J; Ranganathan, S; Villaluna, D; Womer, RB | 1 |
| Ben-Ami, T; Fried, I; Marc, W; Revel-Vilk, S; Waldman, E; Weintraub, M | 1 |
| Becker, RG; Brunetto, AL; Brunetto, AT; da Rocha, A; de Farias, CB; Dos Santos, MP; Dos Santos, RP; Gregianin, LJ; Heinen, TE; Lopez, PL; Rivero, LF; Roesler, R; Silva Filho, MA; Souza, BK | 1 |
| Brons, P; Flucke, U; Salet, MC; Schreuder, B; Vogels, R | 1 |
| Boehme, KA; Handgretinger, R; Kluba, T; Nitsch, J; Riester, R; Schleicher, SB; Traub, F | 1 |
| Azuma, E; Hirayama, M; Imai, H; Iwamoto, S; Komada, Y; Matsumine, A; Miura, Y; Nakatani, K; Toyoda, H; Yodoya, N | 1 |
| Deng, Z; Li, S; Qiu, B; Wang, L; Yang, F; Zhang, S; Zhang, T; Zhu, S | 1 |
| Gilman, AL; Oesterheld, J | 1 |
| Cassoni, A; Craft, AW; Douglas, C; Dunst, J; Grimer, R; Hackshaw, A; Hunold, A; Jürgens, H; Köhler, G; Ladenstein, R; Lewis, I; McTiernan, A; Paulussen, M; Poremba, C; Schuck, A; Spooner, D; van den Berg, H; Whelan, J; Winkelmann, W; Zoubek, A | 1 |
| Arpaci, F; Ataergin, S; Beyzadeoglu, M; Komurcu, S; Oysul, K; Ozet, A; Ozturk, M; Solchaga, L; Surenkok, S; Turan, M | 1 |
| Bielack, SS; Brecht, I; Dantonello, TM; Dickerhoff, R; Gadner, H; Greiner, J; Greulich, M; Harms, D; Herbst, M; Int-Veen, C; Juergens, H; Kirsch, S; Klingebiel, T; Koscielniak, E; Leuschner, I; Marky, I; Scheel-Walter, HG; Schmelzle, R; Schmidt, BF; Treuner, J | 1 |
| Arndt, CA; Bernstein, M; Devidas, M; Dickman, P; Gebhardt, M; Goorin, A; Granowetter, L; Grier, HE; Healey, J; Krailo, M; Leavey, P; Marcus, K; Marina, N; Meyer, J; Miser, J; Perlman, E; Sailer, S; Shamberger, RC; Wang, C; Womer, R | 1 |
| DuBois, SG; Grier, HE | 1 |
| Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
| Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ | 1 |
| Antolín, I; Casado-Zapico, S; García-Santos, G; Martín, V; Rodriguez, C; Rodriguez-Blanco, J; Sánchez-Sánchez, AM | 1 |
| Cozza, R; De Ioris, MA; De Lurentis, C; De Sio, L; Fidani, P; Ilari, I; Jenkner, A; Milano, GM; Pessolano, R | 1 |
| Cai, JY; Chen, J; Dong, L; Jiang, H; Pan, C; Shen, SH; Tang, JY; Xu, M; Xue, HL; Ye, QD; Zhou, M | 1 |
| Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M | 1 |
| Andreoiu, M; Beck, SDW; Brames, MJ; Cheng, L; Ehrlich, Y; Einhorn, LH; Foster, RS; Ulbright, TM | 1 |
| Craft, A; Dirksen, U; Hjorth, L; Jürgens, H; Ladenstein, R; Le Deley, MC; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Pötschger, U; van den Berg, H; Whelan, J | 1 |
| Gibbs, CP; Indelicato, DJ; Islam, S; Keole, SR; Lagmay, JP; Marcus, RB; Morris, CG; Scarborough, MT | 1 |
| Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
| Brookes, KE; Dive, C; Holt, SV; Makin, GW | 1 |
| Cardesa, T; Cruz, O; de Torres, C; Galván, P; Huguet, R; Mora, J; Parareda, A; Rodríguez, E; Salvador, H; Suñol, M; Torner, F | 1 |
| Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
| Douer, D; Liu, SV; Tahbaz, A; Zneimer, S | 1 |
| Delaplace, M; Goré, C; Machet, L; Mélard, P; Perrinaud, A; Vergier, B | 1 |
| Bridge, JA; Hori, T; Huang, D; Kanamori, M; Kimura, T; Suzuki, K; Yasuda, T | 1 |
| Avansino, J; Gow, KW; Hawkins, DS; Meehan, J; Stephenson, J | 1 |
| Burchill, SA; Roundhill, EA | 1 |
| Colpan Oksuz, D; Dervisoglu, S; Hiz, M; Kantarci, F; Koca, S; Molinas Mandel, N; Oner Dincbas, F; Selcukbiricik, F; Tural, D; Turna, H | 1 |
| Patel, S; Rao, P; Richey, SL; Tannir, NM; Wood, CG | 1 |
| Ford, HL; Jedlicka, P; McKinsey, E; Reaves, L; Robin, TP; Smith, A | 1 |
| Abate, ME; Barbieri, E; Bisogno, G; Daolio, P; Eriksson, M; Fagioli, F; Ferrari, S; Gandola, L; Grignani, G; Hall, KS; Lindholm, P; Luksch, R; Picci, P; Podda, M; Prete, A; Ruggieri, P; Smeland, S; Tamburini, A; Tienghi, A | 1 |
| Ash, S; Cohen, IJ; Feinmesser, M; Kornreich, L; Kuperman, AA; Yaniv, I | 1 |
| Baruchel, S; Bernstein, ML; Brown, K; Chuba, PJ; Felgenhauer, JL; Henry, DW; Krailo, MD; Malkin, D; Marina, N; Nieder, ML; Ranganathan, S; Sailer, SL | 1 |
| Andersen, CY; Birkebæk, NH; Clausen, N; Ernst, E; Kjærsgaard, M | 1 |
| Dickman, PS; Dormans, JP; Grier, HE; Healey, JH; Krailo, MD; Marcus, K; Pawel, BR; Sailer, S; Weiss, AR; West, DC; Womer, RB | 1 |
| Aït-Oukhatar, CM; Baunin, C; Benboubker, L; Brisse, H; Couanet, D; Cupissol, D; Defachelles, AS; Laurence, V; Oberlin, O; Ollivier, L; Owens, C; Rey, A; Rubie, H | 1 |
| Iwamoto, Y; Matsuda, S; Matsunobu, T; Sakamoto, A; Tanaka, K | 1 |
| Douglas, J; Felgenhauer, J; Gooley, T; Hawkins, DS; Kreissman, S; Park, J; Pendergrass, TW; Rowley, SD; Sanders, JE; Thomson, B | 1 |
| Adams, R; Albritton, K; Coffin, C; Goldsby, R; Pulsipher, M; Wagner, L | 1 |
| Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 2 |
| Briggs, T; Cannon, S; Cassoni, AM; Cobb, J; Driver, D; Hall-Craggs, M; Kilby, A; McTiernan, A; Michelagnoli, M; Pringle, J; Sandison, A; Strauss, SJ; Whelan, JS; Witt, J | 1 |
| Burdach, S; Dunst, J; Finke, R; Gadner, H; Göbel, U; Haase, R; Haerting, J; Juergens, H; Laws, HJ; Metzner, B; Meyer-Bahlburg, A; Pape, H; van Kaik, B; Wawer, A | 1 |
| Gorlick, R; Healey, JH; Huvos, AG; Kolb, EA; Kushner, BH; LaQuaglia, MP; Laverdiere, C; Meyers, PA; Qin, J; Vu, HT; Wexler, L; Wolden, S | 1 |
| Boehm, R; Joppich, I; Landes, J; Schmid, I; Till, H | 1 |
| Debatin, KM; Fulda, S; Hotfilder, M; Poremba, C; Schäfer, KL; Truckenbrod, B; Van Valen, F; Winkelmann, W | 1 |
| Göbel, U; Laws, HJ; Pape, H; Paulussen, M; van Kaick, B | 1 |
| Blair, IA; Boston, R; Felix, CA; Moate, P; Pang, S; Scavuzzo, J; Zheng, N | 1 |
| Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Allam, A; Bazarbashi, S; El Foudeh, M; El Hassan, I; El Weshi, A; Ezzat, A; Memon, M; Pai, C; Rahal, M; Raja, M | 1 |
| Argon, A; Basaran, M; Bavbek, SE; Camlica, H; Darendeliler, E; Dizdar, Y; Onat, H; Ozger, H; Sakar, B; Yaman, F | 1 |
| Alapetite, C; Anract, P; Babinet, A; Barthier, S; de Pinieux, G; Laurence, V; Palangié, T; Pierga, JY; Pouillart, P | 1 |
| Billups, CA; Davidoff, AM; Fuller, CE; Krasin, MJ; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
| Alektiar, KM; Boland, PJ; Healey, JH; La, TH; Laquaglia, MP; Meyers, PA; Wexler, LH; Wolden, SL | 1 |
| Boldrini, R; Cozza, R; De Ioris, M; De Sio, L; Dominici, C; Donfrancesco, A; Ilari, I; Inserra, A; Jenkner, A; Milano, GM | 1 |
| Billups, CA; Cain, AM; Furman, WL; Hale, GA; Merchant, TE; Navid, F; Pappo, AS; Rao, BN; Santana, VM; Spunt, SL | 1 |
| Craft, A; Juergens, C; Juergens, H; Lewis, I; Michon, J; Oberlin, O; Paulussen, M; Weston, C; Whelan, J; Zoubek, A | 1 |
| Mai, WY; Nguyen, TX; Paulino, AC; Teh, BS; Wen, BC | 1 |
| Driver, D; Kilby, AM; McTiernan, A; Michelagnoli, MP; Whelan, JS | 1 |
| Guo, W; Tang, S; Tang, XD; Yang, Y | 1 |
| Katski, K; Kołłataj, B; Kołłataj, W; Majewski, M; Pijanowska, M; Sikora, P; Zajaczkowska, M | 1 |
| Bernstein, M; Chen, Z; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, M; Laurie, F; Miser, JS; Tarbell, NJ; Yock, TI | 1 |
| Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
| Naru, T; Nawaz, FH; Rizvi, J | 1 |
| Abe, S; Ishii, T; Kawai, A; Matsumine, A; Obata, H; Ozaki, T; Tanaka, K; Tsuchiya, H; Ueda, T; Yabe, H | 1 |
| Al Harbi, T; Al-Faris, N; Doyle, J; Gassas, A; Goia, C; Pappo, A | 1 |
| Burke, MJ; Duerst, RE; Jacobsohn, DA; Kletzel, M; Walterhouse, DO | 1 |
| Boven, E; Meijer, OW; Smorenburg, CH; van Groeningen, CJ; Visser, M | 1 |
| Abla, O; Dror, Y; Shago, M | 1 |
| Billups, CA; Krasin, MJ; Liu, T; Navid, F; Rao, BN; Rodríguez-Galindo, C | 1 |
| Advani, SH; Badrinath, Y; Bajpai, S; Gladstone, B; Kapoor, G; Nair, CN | 1 |
| Bart, F; Cardot, E; Duquenne, O; Gosselin, B; Marquette, CH; Tonnel, AB | 1 |
| Berger, M; Chassagne, J; de Lumley, L; Deméocq, F; Kanold, J; Lutz, P; Malpuech, G; Plantaz, D; Rapatel, C; Vannier, JP | 1 |
| Aledo, A; Boland, P; Casper, ES; Gerald, WL; Healey, JH; Heller, G; Kushner, BH; La Quaglia, MP; Meyers, PA; Wollner, N | 1 |
| Hamada, M; Inoue, H; Nakagawa, Y; Ozaki, T; Sugihara, S | 1 |
| Cowie, FJ; Dick, G; Flanagan, RJ; Judson, I; McCarthy, PT; Phillips, M; Pinkerton, CR | 1 |
| Castel, V; Esquembre, C; Ferrís, J; Lopez-Andrew, JA; Senent, ML; Verdeguer, A | 1 |
| Burdach, S; Dilloo, D; Jürgens, H; Körholz, D; Koscielniak, E; Mauz-Körholz, C; Nürnberger, W; Pape, H; Paulussen, M; Peters, C | 1 |
| Bacci, G; Barbieri, E; Casadei, R; Fabbri, N; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Rosito, P; Ruggieri, P | 1 |
| Carstens, C; Lowry, PA | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Campanacci, M; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P | 1 |
| Avila, N; Balis, FM; DeLaney, TF; Hijazi, YM; Horowitz, ME; Jacobson, J; Jarosinski, P; Steinberg, SM; Tsokos, M; Weaver-McClure, L; Wexler, LH | 1 |
| Bacci, G; Barbieri, E; Brach Del Prever, A; Ferrari, S; Forni, C; Iantorno, D; Mercuri, M; Rosito, P; Ruggieri, P | 1 |
| Fisher, C; Harmer, CL; Judson, IR; Thomas, JM; Verrill, MW; Wiltshaw, E | 1 |
| Bacci, G; Barbieri, E; Brach del Prever, A; Ferrari, S; Forni, C; Mercuri, M; Picci, P; Rosito, P; Tienghi, A | 1 |
| Ahrens, S; Dunst, J; Hillmann, A; Hofmann, J; Jürgens, H; Paulussen, M; Rübe, C; Schuck, A; Willich, N | 1 |
| Ahmad, R; Davis, M; Mayol, BR; Rougraff, BT | 1 |
| Cain, AM; Greenwald, C; Marina, NM; Meyer, WH; Pappo, AS; Parham, DM; Poquette, CA; Pratt, CB; Rao, BN | 1 |
| Felgenhauer, J; Hawkins, D; Radich, J; Thomson, B | 1 |
| Bella, S; Burnelli, R; Garaventa, A; Locatelli, F; Melchionda, F; Paolucci, G; Pession, A; Prete, A | 1 |
| Bacchini, P; Bacci, G; Bertoni, F; Donati, D; Ferrari, S; Forni, C; Longhi, A; Manfrini, M; Picci, P; Rimondini, S | 1 |
| Daller, RT; Fenton, JG; Miser, JS; Womer, RB | 1 |
| Kushner, BH; Meyers, PA | 1 |
| Brandao, L; Cain, AM; Kun, LE; McCarville, MB; Pappo, AS; Poquette, CA; Spunt, SL | 1 |
| Hung, MC; Jia, SF; Kleinerman, ES; Zhou, Z | 1 |
| Baker, DL; Chan, KW; Davis, JH; Dickman, PS; Gerbing, RB; Gorlick, RG; Grovas, A; Herzog, CE; Krailo, MD; Ladanyi, M; Lindsley, KL; Liu-Mares, W; Meyers, PA; Nachman, JB; Sailer, SL; Sieger, L; Wadman, J | 1 |
| Guidos, BJ; Selvaggi, SM | 1 |
| Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
| Bucana, CD; Jia, SF; Kleinerman, ES; Wang, Y; Zhou, RR; Zhou, Z | 1 |
| Dritschilo, A; McDermott, F; Notario, V; Rouzaut, A; Soldatenkov, VA; Trofimova, IN | 1 |
| Ahrens, S; Dunst, J; Jürgens, H; Könemann, S; Paulussen, M; Rübe, C; Rübe, CE; Schuck, A; Willich, N | 1 |
| Fletcher, B; Kun, L; Marina, N; Meyer, WH; Parham, D; Pratt, CB; Rao, B; Roberson, P | 1 |
| Gedikoğlu, G; Zülfikar, B | 1 |
| Burdach, S; Dilloo, D; Gadner, H; Göbel, U; Nürnberger, W; Paulussen, M; Peters, C; Voehringer, R; Wernet, P; Wurm, R | 1 |
| Akiba, Y; Fujita, Y; Ikushima, Y; Ishida, S; Ohosaki, Y; Onodera, S; Sakai, E; Saotome, K; Shimizu, T; Tagaki, S | 1 |
| Fletcher, BD; Jenkins, JJ; Lemmi, MA; Marina, NM; Meyer, WH; Parham, DM; Slade, W | 1 |
| Chasen, MR; Falkson, G; Falkson, HC | 1 |
| Lampkin, BC; Wong, KY | 1 |
9 review(s) available for etoposide and Sarcoma, Ewing
| Article | Year |
|---|---|
Clinical characteristics of primary cutaneous and subcutaneous Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prognosis; Progression-Free Survival; Sarcoma, Ewing; Skin Neoplasms; Vincristine | 2023 |
Primary Ewing sarcoma of the larynx with distant metastasis: a case report and review of the literature.
Topics: Antineoplastic Agents; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Dactinomycin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Laryngeal Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2019 |
Risk stratification of pulmonary toxicities in the combination of whole lung irradiation and high-dose chemotherapy for Ewing sarcoma patients with lung metastases: a review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Combined Modality Therapy; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Drug Administration Schedule; Etoposide; Female; Humans; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Male; Melphalan; Procedures and Techniques Utilization; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Respiratory Function Tests; Risk; Sarcoma, Ewing; Whole-Body Irradiation; Young Adult | 2020 |
Efficacy Comparison of Six Chemotherapeutic Combinations for Osteosarcoma and Ewing's Sarcoma Treatment: A Network Meta-Analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Randomized Controlled Trials as Topic; Sarcoma, Ewing; Survival Rate | 2018 |
Extraskeletal Ewing's sarcoma of the thoracic epidural space: case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epidural Neoplasms; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Molecular Diagnostic Techniques; Neoplasm Recurrence, Local; Sarcoma, Ewing; Thoracic Vertebrae; Vincristine | 2011 |
Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Carmustine; Cisplatin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prognosis; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2005 |
Secondary acute promyelocytic leukemia in a child treated with epipodophyllotoxins.
Topics: Bone Neoplasms; Child; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Pelvic Bones; Sarcoma, Ewing; Teniposide | 1994 |
How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Melphalan; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Thiotepa; Vincristine; Whole-Body Irradiation | 2001 |
Indications for and benefits of intensive therapies in treatment of childhood cancers.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Etoposide; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Methotrexate; Neoplasms; Osteosarcoma; Risk; Sarcoma, Ewing | 1986 |
46 trial(s) available for etoposide and Sarcoma, Ewing
| Article | Year |
|---|---|
High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Male; Melphalan; Prospective Studies; Sarcoma, Ewing; Vincristine | 2022 |
Radiation Therapy Dose Escalation in Unresectable Ewing Sarcoma: Final Results of a Phase 3 Randomized Controlled Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Young Adult | 2022 |
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 2023 |
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Busulfan; Child; Child, Preschool; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult; Zoledronic Acid | 2020 |
Extraskeletal Ewing sarcoma in children, adolescents, and young adults. An analysis of three prospective studies of the Cooperative Weichteilsarkomstudiengruppe (CWS).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult | 2021 |
Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
Topics: Administration, Metronomic; Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Celecoxib; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Double-Blind Method; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasms; Response Elements; Retreatment; Sarcoma, Ewing; Survival Rate; Thalidomide; Time Factors | 2017 |
Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Topics: Administration, Metronomic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Survival Rate; Tamoxifen; Young Adult | 2019 |
Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Male; Melphalan; Mesna; Neoplasm Staging; Prognosis; Prospective Studies; Sarcoma, Ewing; Sex Factors; Survival Rate; Vincristine; Young Adult | 2014 |
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Consolidation Chemotherapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Sarcoma, Ewing; Treatment Outcome; Vincristine; Young Adult | 2014 |
Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Proportional Hazards Models; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2015 |
Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Sarcoma, Ewing; Survival Rate; Thiotepa; Vincristine; Young Adult | 2015 |
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Sarcoma, Ewing; Vincristine | 2008 |
Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms; Vincristine; Young Adult | 2009 |
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2009 |
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Time Factors; Treatment Outcome; Tumor Burden; Vincristine | 2009 |
Results of RS-99 protocol for childhood solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Sarcoma, Ewing; Tamoxifen; Vincristine | 2010 |
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prognosis; Risk Factors; Sarcoma, Ewing; Vincristine | 2010 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Recurrence; RNA-Binding Protein EWS; Sarcoma, Ewing; Survival Rate; Vincristine | 2011 |
A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Pyrazoles; Radiotherapy; Sarcoma, Ewing; Sulfonamides; Vinblastine; Young Adult | 2013 |
Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Infant; Middle Aged; Prospective Studies; Sarcoma, Ewing; Vincristine; Young Adult | 2012 |
Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Male; Middle Aged; Recurrence; Sarcoma, Ewing | 2013 |
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma; Sarcoma, Ewing; Survival Rate; Treatment Failure; Vincristine | 2003 |
Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine | 2003 |
Plasma etoposide catechol increases in pediatric patients undergoing multiple-day chemotherapy with etoposide.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Area Under Curve; Catechols; Child; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Neoplasms; Sarcoma, Ewing; Time Factors | 2004 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experie
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Vincristine | 2006 |
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Vincristine | 2006 |
Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Pelvic Bones; Radiotherapy, Adjuvant; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2006 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Use of G-CSF alone to mobilize peripheral blood stem cells for collection from children.
Topics: Child; Child, Preschool; Cyclophosphamide; Erythroid Precursor Cells; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infant, Newborn; Neuroblastoma; Sarcoma, Ewing | 1994 |
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Remission Induction; Risk Factors; Sarcoma, Ewing; Survival Rate; Vincristine | 1995 |
Salvage chemotherapy for recurrent Ewing's sarcomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Salvage Therapy; Sarcoma, Ewing; Treatment Outcome | 1995 |
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasms; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Rhabdomyosarcoma; Sarcoma, Ewing; Verapamil; Wilms Tumor | 1995 |
No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Middle Aged; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1993 |
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Heart Failure; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1996 |
Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1998 |
Radiotherapy in Ewing's sarcoma and PNET of the chest wall: results of the trials CESS 81, CESS 86 and EICESS 92.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Thorax; Vincristine | 1998 |
Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Neuroectodermal Tumors, Primitive; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Rate | 1999 |
Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neuroblastoma; Prognosis; Rhabdomyosarcoma; Sarcoma, Ewing; Thiotepa | 1999 |
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2001 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
Improved relapse free survival in patients with poor prognosis Ewing's sarcoma after consolidation with hyperfractionated total body irradiation and fractionated high dose melphalan followed by high dose etoposide and hematopoietic rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Combined Modality Therapy; Etoposide; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Melphalan; Radiotherapy Dosage; Remission Induction; Sarcoma, Ewing; Survival Rate; Whole-Body Irradiation | 1991 |
106 other study(ies) available for etoposide and Sarcoma, Ewing
| Article | Year |
|---|---|
Feasibility and safety of outpatient administration of ifosfamide and etoposide for pediatric patients with Ewing sarcoma in a resource-limited setting amid the COVID-19 pandemic.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; COVID-19 Drug Treatment; Etoposide; Feasibility Studies; Humans; Ifosfamide; Outpatients; Pandemics; Retrospective Studies; Sarcoma, Ewing | 2022 |
Outcomes of Pediatric Patients With Metastatic Ewing Sarcoma Treated With Interval Compression.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasms, Second Primary; Sarcoma, Ewing; Vincristine | 2023 |
Analysis of stem cell collections in adult patients with Ewing sarcoma.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Child; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Stem Cells; Vincristine; Young Adult | 2022 |
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Enzyme Therapy; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; Pancreas; Pancreatic Neoplasms; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2022 |
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver Disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cholestasis; Cholestasis, Intrahepatic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
The effectiveness and mechanical properties of chemotherapy-impregnated cement in Ewing sarcoma.
Topics: Antineoplastic Agents; Bone Cements; Bone Neoplasms; Doxorubicin; Etoposide; Humans; Sarcoma, Ewing | 2023 |
Treatment outcomes of extraskeletal Ewing sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2023 |
Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Recurrence, Local; Retrospective Studies; Sarcoma, Ewing; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2020 |
Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cyclophosphamide; Depsipeptides; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Etoposide; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone Demethylases; Humans; Hydrazines; Irinotecan; Sarcoma, Ewing; Sulfonamides; Vincristine | 2019 |
Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines.
Topics: Arsenic Trioxide; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Multidrug Resistance-Associated Proteins; Phosphorylation; Sarcoma, Ewing; Zinc Finger Protein GLI1 | 2020 |
Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2019 |
Challenges in the management of localized Ewing sarcoma in a developing country.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Patient Compliance; Prognosis; Retrospective Studies; Sarcoma, Ewing; Sepsis; Survival Rate; Vincristine | 2020 |
A Case of Ewing Sarcoma of the Bladder Presenting in Early Infancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematuria; Humans; Ifosfamide; Infant; Sarcoma, Ewing; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 2021 |
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing country.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Developing Countries; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Vincristine; Young Adult | 2021 |
Successful collection of peripheral blood stem cells upon VIDE chemomobilization in sarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Peripheral Blood Stem Cells; Sarcoma, Ewing; Vincristine; Young Adult | 2017 |
Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Extremities; Humans; Ifosfamide; Infant; Middle Aged; Neoplasm Recurrence, Local; Pelvic Bones; Retrospective Studies; Sarcoma, Ewing; Treatment Failure | 2017 |
Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Case-Control Studies; Cementation; Child; Child, Preschool; Combined Modality Therapy; Curettage; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Phenol; Recovery of Function; Retrospective Studies; Sarcoma, Ewing; Sclerosing Solutions; Sclerotherapy; Wound Healing | 2019 |
Safety and Cost-effectiveness of Outpatient Administration of High-dose Chemotherapy in Children With Ewing Sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neutropenia; Outpatients; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2019 |
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
Topics: Adolescent; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Osteosarcoma; Sarcoma, Ewing | 2020 |
Multidisciplinary therapy including proton beam radiotherapy for a Ewing sarcoma family tumor of maxillary sinus in a 4-year-old girl.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Maxilla; Maxillary Sinus Neoplasms; Proton Therapy; Sarcoma, Ewing; Vincristine | 2013 |
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recurrence; Sarcoma, Ewing; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2013 |
Extraskeletal Ewing's Sarcoma: insight into a ten years follow-up.
Topics: Abdominal Neoplasms; Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Intestines; Radiotherapy, Adjuvant; Rupture, Spontaneous; Sarcoma, Ewing; Survivors; Tomography, X-Ray Computed; Vincristine | 2013 |
In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Butyric Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diphosphonates; Doxorubicin; Drug Synergism; Etoposide; Histamine Antagonists; Histone Deacetylase Inhibitors; Humans; Imidazoles; Molecular Targeted Therapy; Sarcoma, Ewing; Tumor Stem Cell Assay; Vincristine; Zoledronic Acid | 2014 |
[Hypersensitivity reaction to etoposide. A case report].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Femur; Humans; Male; Sarcoma, Ewing | 2014 |
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Salvage Therapy; Sarcoma, Ewing; Survival Rate; Young Adult | 2015 |
Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukocyte Count; Male; Neoadjuvant Therapy; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 2015 |
Suberoylanilide hydroxamic acid synergistically enhances the antitumor activity of etoposide in Ewing sarcoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Sarcoma, Ewing; Vorinostat | 2015 |
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Caspases; Cell Proliferation; Etoposide; Flow Cytometry; Heterocyclic Compounds, 4 or More Rings; Humans; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma, Ewing; Sirtuin 1; Stilbenes; Tumor Cells, Cultured; Vincristine | 2016 |
Identification of Discrete Prognostic Groups in Ewing Sarcoma.
Topics: Adolescent; Adult; Age Factors; Bone Neoplasms; Child; Child, Preschool; Databases, Factual; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Sarcoma, Ewing; SEER Program | 2016 |
PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dacarbazine; Dactinomycin; Doxorubicin; Drug Synergism; Etoposide; G2 Phase Cell Cycle Checkpoints; Humans; Ifosfamide; Metabolic Networks and Pathways; Mitochondria; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Sarcoma, Ewing; Temozolomide; Vincristine | 2015 |
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.
Topics: Alternative Splicing; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DEAD-box RNA Helicases; DNA Damage; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Oncogene Proteins, Fusion; Phosphorylation; Proto-Oncogene Protein c-fli-1; RNA Polymerase II; RNA Precursors; RNA-Binding Protein EWS; RNA, Messenger; Sarcoma, Ewing; Signal Transduction; Time Factors; Topoisomerase II Inhibitors; Transfection; Ultraviolet Rays | 2015 |
Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Topotecan; Vincristine | 2016 |
Ewing Sarcoma: A 15-Year Experience of a Single Center With the MSKCC P6 Treatment Protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2016 |
Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
Topics: Antineoplastic Agents; Azepines; Benzamides; Brain-Derived Neurotrophic Factor; Carbazoles; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Enzyme Inhibitors; Etoposide; Humans; Indole Alkaloids; Membrane Glycoproteins; Nerve Growth Factor; Receptor, trkA; Receptor, trkB; RNA, Messenger; Sarcoma, Ewing; Tubulin; Vincristine | 2016 |
Maturation toward neuronal tissue in a Ewing sarcoma of bone after chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calmodulin-Binding Proteins; Cell Differentiation; Chemotherapy, Adjuvant; Child; Doxorubicin; Etoposide; Femoral Neoplasms; Femur; Ganglioneuroblastoma; Gene Rearrangement; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Prognosis; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2016 |
Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Bone Neoplasms; Drug Synergism; Etoposide; Flow Cytometry; Humans; Oxides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Tumor Cells, Cultured | 2016 |
Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Methotrexate; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Osteosarcoma; Proto-Oncogene Protein c-fli-1; Remission Induction; RNA-Binding Protein EWS; Sarcoma, Ewing; Vincristine | 2017 |
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma.
Topics: Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Myeloablative Agonists; Neoplasm Metastasis; Prospective Studies; Risk; Risk Factors; Sarcoma, Ewing; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Sarcoma, Ewing; Treatment Outcome; Young Adult | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine | 2009 |
Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Drug Synergism; Etoposide; Flow Cytometry; Humans; Ifosfamide; Melatonin; Sarcoma, Ewing; Vincristine | 2010 |
Toxicity of high-dose chemotherapy with etoposide, thiotepa and CY in treating poor-prognosis Ewing's sarcoma family tumors: the experience of the Bambino Gesù Children's Hospital.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kinetics; Male; Prognosis; Retrospective Studies; Sarcoma, Ewing; Thiotepa | 2010 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Rate; Teratoma; Treatment Outcome; Vincristine; Young Adult | 2010 |
Chest wall Ewing sarcoma family of tumors: long-term outcomes.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Recurrence, Local; Radiotherapy Dosage; Sarcoma, Ewing; Thoracic Wall; Time Factors; Vincristine; Young Adult | 2011 |
Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Bone Neoplasms; Child; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Oligonucleotides; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; X-Linked Inhibitor of Apoptosis Protein | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
Therapy-related acute myeloid leukemia following treatment with trabectedin for Ewing's sarcoma.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Dioxoles; Etoposide; Fatal Outcome; Female; Gene Deletion; Gene Rearrangement; Humans; Leukemia, Myeloid, Acute; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Sarcoma, Ewing; Tetrahydroisoquinolines; Topoisomerase Inhibitors; Trabectedin; Young Adult | 2011 |
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Topics: 12E7 Antigen; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Calmodulin-Binding Proteins; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Combined Modality Therapy; Dactinomycin; Disease Management; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Reoperation; RNA-Binding Protein EWS; RNA-Binding Proteins; Sarcoma, Ewing; Shoulder; Skin Neoplasms; Vincristine; Young Adult | 2011 |
Ewing sarcoma/primitive neuroectodermal tumor arising from the adrenal gland in an adolescent.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Neuroectodermal Tumors, Primitive, Peripheral; Radiotherapy; Sarcoma, Ewing; Vincristine | 2011 |
Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Line, Tumor; Cell Membrane; Dactinomycin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fenretinide; Fluoresceins; Fluorescent Dyes; Gene Expression; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Mitochondria; Protein Transport; Sarcoma, Ewing; Vincristine | 2012 |
Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Incidence; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2012 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamide; Induction Chemotherapy; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neuroectodermal Tumors, Primitive; Radiography; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2012 |
EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Mesenchymal Stem Cells; MicroRNAs; Oncogene Proteins, Fusion; Protein Tyrosine Phosphatases; Proto-Oncogene Protein c-fli-1; RNA-Binding Protein EWS; Sarcoma, Ewing | 2012 |
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Melphalan; Myeloablative Agonists; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Stem Cell Transplantation; Vincristine; Young Adult | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Diagnostic Errors; Doxorubicin; Etoposide; Female; Hamartoma; Humans; Ifosfamide; Liver Neoplasms; Mesoderm; Prognosis; Sarcoma, Ewing; Vincristine; Young Adult | 2013 |
Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cryopreservation; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Fertility Preservation; Follicle Stimulating Hormone; Humans; Ifosfamide; Ovary; Primary Ovarian Insufficiency; Prognosis; Puberty; Radiotherapy, Conformal; Sarcoma, Ewing; Vincristine | 2013 |
High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Ewing; Survival Rate; Treatment Outcome | 2002 |
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Mesna; Neoplasm Metastasis; Remission Induction; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2002 |
Unexpected pleural effusions in 3 pediatric patients treated with STI-571.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Camptothecin; Child; Combined Modality Therapy; Edema; Enzyme Inhibitors; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Irinotecan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Lung Neoplasms; Male; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Piperazines; Pleural Effusion; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction; Sarcoma, Ewing; Testis; Topotecan | 2002 |
Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Doxorubicin; Etoposide; Feasibility Studies; Female; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Male; Mesna; Neoplasm Staging; Sarcoma, Ewing; Treatment Outcome; Vincristine | 2003 |
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation | 2003 |
Ileoileal intussusception caused by a Ewing sarcoma tumour. An unusual case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Digestive System Surgical Procedures; Doxorubicin; Etoposide; Humans; Ifosfamide; Ileal Diseases; Ileal Neoplasms; Intussusception; Male; Sarcoma, Ewing; Stem Cell Transplantation; Treatment Outcome; Vincristine | 2003 |
Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Cells; Bone Marrow Neoplasms; Cell Survival; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Membrane Glycoproteins; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2003 |
Relapse after high-dose therapy in relapsed Ewing's tumor patients: effects of maintenance chemotherapy in two selected patients?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retreatment; Sarcoma, Ewing | 2003 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Salvage Therapy; Sarcoma, Ewing; Survival Analysis | 2004 |
Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine | 2004 |
Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome; Vincristine | 2005 |
Radiation therapy for Ewing's sarcoma: results from Memorial Sloan-Kettering in the modern era.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Neoplasms, Second Primary; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Sarcoma, Ewing; Statistics, Nonparametric; Vincristine | 2006 |
Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome; United States; Vincristine | 2007 |
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Busulfan; Combined Modality Therapy; Disease Progression; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Sarcoma, Ewing; Treatment Outcome | 2006 |
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome | 2006 |
[Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Dactinomycin; Doxorubicin; Etoposide; Fanconi Syndrome; Femur; Humans; Ifosfamide; Male; Sarcoma, Ewing; Vincristine | 2006 |
Juvenile Ewing sarcoma presenting as a pelvic mass.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Sarcoma, Ewing | 2007 |
Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan: the Japanese Musculoskeletal Oncology Group cooperative study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Male; Middle Aged; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Treatment Outcome | 2007 |
Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infection Control; Kaplan-Meier Estimate; Melphalan; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Postoperative Care; Retrospective Studies; Risk; Salvage Therapy; Sarcoma, Ewing; Topotecan; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Vincristine | 2007 |
Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive; Pelvic Bones; Peripheral Blood Stem Cell Transplantation; Remission Induction; Risk; Sarcoma, Ewing; Scapula; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Netherlands; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 10; Chromosomes, Human, X; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Sarcoma, Ewing; Translocation, Genetic | 2007 |
Prognostic factors for local and distant control in Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Dose Fractionation, Radiation; Etoposide; Female; Humans; Ifosfamide; Incidence; Infant; Male; Medical Records; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Treatment Failure | 2008 |
Calla positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Etoposide; Humans; Male; Neoplasms, Second Primary; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Ewing; Tibia | 1995 |
[Extraosseous Ewing's sarcoma with thoracic localization].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Sarcoma, Ewing; Thoracic Neoplasms; Tomography, X-Ray Computed; Vincristine | 1994 |
Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cohort Studies; Combined Modality Therapy; Cytokines; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Prognosis; Recurrence; Remission Induction; Sarcoma, Ewing; Survival Analysis; Whole-Body Irradiation | 1993 |
Intense gallbladder uptake associated with chemotherapy. An unusual finding in pediatric skeletal scintigraphy.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Child; Etoposide; Female; Gallbladder; Humans; Ifosfamide; Liver; Male; Osteosarcoma; Radionuclide Imaging; Sarcoma, Ewing; Technetium Tc 99m Medronate; Tissue Distribution | 1995 |
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1995 |
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leg; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Vincristine | 1997 |
The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Mesna; Middle Aged; Neuroectodermal Tumors, Primitive; Neutropenia; Sarcoma, Ewing; Vincristine | 1997 |
Extraskeletal Ewing's sarcoma.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Retrospective Studies; Sarcoma, Ewing; Survival Rate; Vincristine | 1999 |
RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Purging; Bone Neoplasms; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 22; Combined Modality Therapy; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Male; Mesna; Neoplasm Proteins; Neoplastic Cells, Circulating; Oncogene Proteins, Fusion; Paired Box Transcription Factors; PAX3 Transcription Factor; Proto-Oncogene Protein c-fli-1; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma, Alveolar; RNA-Binding Protein EWS; Sarcoma, Ewing; Sensitivity and Specificity; Soft Tissue Neoplasms; Transcription Factors; Translocation, Genetic; Vincristine | 1999 |
Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Italy; L-Lactate Dehydrogenase; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Retrospective Studies; Sarcoma, Ewing; Vincristine | 2000 |
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Male; Pilot Projects; Prospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survival Analysis; Vincristine | 2000 |
Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lung Neoplasms; Male; Radiation Pneumonitis; Radiotherapy; Remission Induction; Retrospective Studies; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
Topics: Adenoviridae; Adenovirus E1A Proteins; Antineoplastic Agents; Cell Division; Cisplatin; DNA Topoisomerases, Type II; Down-Regulation; Doxorubicin; Etoposide; Gene Transfer Techniques; Genes, erbB-2; Genetic Therapy; Genetic Vectors; Humans; Receptor, ErbB-2; Sarcoma, Ewing; Topoisomerase II Inhibitors; Transduction, Genetic; Tumor Cells, Cultured; Up-Regulation | 2001 |
Immature teratoma of the ovary on fluid cytology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Biomarkers, Tumor; Bleomycin; Child; Cisplatin; Cytodiagnosis; Diagnosis, Differential; Etoposide; Female; Humans; Immunoenzyme Techniques; Lymphoma, Non-Hodgkin; Neuroblastoma; Ovarian Neoplasms; Rhabdomyosarcoma, Embryonal; Sarcoma, Ewing; Teratoma; Wilms Tumor | 2001 |
Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Down-Regulation; Etoposide; Genetic Therapy; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Nude; Microscopy, Fluorescence; Models, Genetic; Receptor, ErbB-2; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Time Factors; Tumor Cells, Cultured | 2002 |
Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1.
Topics: Apoptosis; DNA Damage; Etoposide; Humans; Nucleic Acid Synthesis Inhibitors; Oncogene Proteins, Fusion; Poly(ADP-ribose) Polymerases; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Protein c-fli-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; RNA-Binding Protein EWS; Sarcoma, Ewing; Transcription Factors; Tumor Cells, Cultured | 2002 |
Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Pilot Projects; Postoperative Care; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Survival Analysis; Time Factors; Vincristine | 2002 |
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Ifosfamide; Male; Pilot Projects; Sarcoma, Ewing; Treatment Outcome | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
[Two cases of Ewing's sarcoma originating from the adult rib].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Ribs; Sarcoma, Ewing | 1991 |
Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Evaluation Studies as Topic; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Sarcoma, Ewing | 1990 |
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer.
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Mesna; Middle Aged; Nausea; Ovarian Neoplasms; Sarcoma, Ewing; Testicular Neoplasms; Vomiting | 1990 |